Esperion Therapeutics Inc. - ESPR - stock price prediction, stock price target, analyst ratings from 9 analysts
Esperion Therapeutics Inc. has a share price target of US$ 7, revenue growth forecast of 4.5%, and profit growth estimate of 97.4% for FY25, based on top 9 analyst calls.